Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat

Diabetes, Obesity and Metabolism

Volumn 9, Issue 1, 2007, Pages 87-95

  Proctor, S D ^a   Kelly, S E ^a   Stanhope, K L ^b   Havel, P J ^b   Russell, Jim C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiponectin; Chromium; Conjugated linoleic acid; Glomerular sclerosis; Insulin resistance; JCR:LA cp rat; Metabolic syndrome; Prediabetes; Vasculopathy

Indexed keywords

ACETYLCHOLINE; ADIPONECTIN; ALBUMIN; CHOLESTEROL; CHOLESTEROL ESTER; CHROMIUM PICOLINATE; CONJUGATED LINOLEIC ACID; INSULIN; LIPID; PHOSPHOLIPID; TONALIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL FUNCTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DRUG POTENTIATION; FOOD INTAKE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; VASCULAR RING; VASODILATATION; WEIGHT REDUCTION;

EID: 33845548609     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00578.x     Document Type: Article

References (42)

1. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non- insulin-dependent diabetic and nondiabetic subjects. Circulation 1990; 82: 27-36.
2. Després J-P, Lamarche B, Mauriège P et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
3. O'Brien SF, Russell JC. Insulin resistance and vascular wall function: lessons from animal models. Endocrinol Metab 1997; 4: 155-162.
4. Wahle WJ, Heys DH, Rotondo D. Conjugated linoleic acids: Are they beneficial or detrimental to health? Prog Lipid Res 2004; 43: 553-587.
5. Taylor GT, Zahradka P. Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am J Clin Nutr 2004; 79 (Suppl.): 1164S-1168S.
6. Choi JS, Jung MH, Park HS, Song J. Effect of conjugated linoleic acid isomers on insulin resistance and mRNA levels of genes regulating energy metabolism in high-fat-fed rats. Nutrition 2004; 20: 1008-1017.
7. Teachy MK, Taylor ZC, Maier T et al. Interactions of conjugated linoleic acid and lipoic acid on insulin action in the obese Zucker rat. Metabolism 2003; 52: 1167-1174.
8. McLeod RS, LeBlanc AM, Langille MA, Mitchell PL, Currie DL. Conjugated linoleic acids, atherosclerosis, and hepatic very-low-density lipoprotein metabolism. Am J Clin Nutr 2004; 79 (Suppl.): 1169S-1174S.
9. 1a production in bovine aortic endothelial cells by conjugated linoleic acid. Endothelium 2004; 11: 211-220.
10. Ogborn MR, Nitschmann E, Bankovic-Calic N et al. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. Kidney Int 2003; 64: 1214-1221.
11. Havel PJ. Update on adipocyte hormones: Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53 (Suppl. 1): S143-S151.
12. Nagao K, Inoue N, Wang YM, Yanagita T. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun 2003; 310: 562-566.
13. Fernandez-Real JM, Castro A, Vazquez G et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 2004; 27: 739-745.
14. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care 2004; 27: 2741-2751.
15. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 2002; 132: 1107-1114.
16. Miranda ER, Dey CS. Effect of chromium and zinc on insulin signaling in skeletal muscle cells. Biol Trace Elem Res 2004; 101: 19-36.
17. Rhodes MC, Hébert CD, Herbert RA et al. Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem Toxicol 2005; 43: 21-29.
18. Wu-Peng XS, Chua SC Jr, Okada N, Liu S-M, Nicolson M, Leibel RL. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor: Evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 1997; 46: 513-518.
19. Russell JC, Bar-Tana J, Shillabeer G et al. Development of insulin resiRtance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes 1998; 47: 770-778.
20. Russell JC, Graham SE, Richardson M. Cardiovascular disease in the JCR:LA-cp rat. Mol Cell Biochem 1998; 188: 113-126.
21. Russell JC, Graham SE, Dolphin PJ. Glucose tolerance and insulin resiEtance in the JCR:LA-cp rat: effect of miglitol (Bay m1099). Metabolism 1999; 48: 701-706.
22. O'Brien SF, Russell JC, Davidge ST. Vascular wall dysfunction in JCR:LE-cp rats: effects of age and insulin resistance. Am J Physiol 1999; 277: C987-C993.
23. Richardson M, Schmidt AM, Graham SE, Achen B, DeReske M, Russell JC. Vasculopathy and insulin resistance in the JCR:LA-cp rat. Atherosclerosis 1998; 138: 135-146.
24. Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β,β′-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol 1995; 15: 918-923.
25. Russell JC, Dolphin PJ, Graham SE, Amy RM, Brindley DN. Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by d-fenfluramine. Diabetologia 1998; 41: 380-389.
26. Russell JC, Kelly SE, Schäfer S. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat. J Cardiovasc Pharmacol 2004; 44: 258-265.
27. Russell JC, Ravel D, Pégorier J-P et al. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat. J Pharmacol Exp Ther 2000; 295: 753-760.
28. Proctor SD, Kelly SE, Russell JC. Improvement of micro- and macro-vascular function and inhibition of glomerular sclerosis in insulin-resistant JCR:LA- cp rats by a novel complex of arginine silicate. Diabetologia 2005; 48: 1925-1932.
29. McKendrick JD, Salas E, DubéGP, Murat J, Russell JC, Radomski MW. Inhibition of nitric oxide generation unmasks vascular dysfunction in JCR:LA-cp rats. Br J Pharmacol 1998; 124: 361-369.
30. Kuksis A, Myher JJ, Geher K et al. Comparative determination of plasma cholesterol and triacylglycerol levels by automated gas - liquid chromatographic and autoanalyzer techniques. J Chromatogr 1978; 146: 393-412.
31. Schäfer S, Steioff K, Linz W, Bleich M, Busch AE, Löhn M. Chronic vasopeptidase inhibition normalizes diabetic endothelial dysfunction. Eur J Pharmacol 2004; 484: 361-362.
32. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978; 235: E97-E102.
33. Wargent E, Sennitt MV, Stocker C et al. Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: Possible involvement of PPAR activation. Lipids Health Dis 2005; 4: 3.
34. Pal S, Takechi R, Ho SS. Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells. Clin Chem Lab Med 2005; 43: 269-274.
35. Yu-Poth S, Yin D, Zhao G, Kris-Etherton PM, Etherton TD. Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells. J Nutr 2004; 134: 68-71.
36. Clodfelder BJ, Vincent JB. The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem 2005; 10: 383-393.
37. Fasshause M, Paschke R, Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 2004; 86: 779-784.
38. Alemzadeh R, Tushaus KM. Modulation of adipoinsular axis in prediabetic Zucker diabetic fatty rats by diazoxide. Endocrinology 2004; 145: 5476-5484.
39. Altomonte J, Harbaran S, Richter A, Dong H. Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism 2003; 52: 958-963.
40. Nagao K, Inoue N, Wang Y-M et al. Dietary conjugated linoleic Acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Nutr 2005; 135: 9-13.
41. Pajvani UB, Xueliang Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormone acrp30/adiponectin. J Biol Chem 2003; 278: 9073-9085.
42. Moore JW, Maher MA, Banz WJ, Zemel MB. Chromium picolinate modulates rat vascular smooth muscle cell intracellular calcium metabolism. J Nutr 1998; 128: 180-184.